The National Cancer Institute (NCI) Office of Cancer Nanotechnology Research (OCNR) is working together with the NCI Center for Biomedical Informatics and Information Technology (CBIIT) to submit nanotechnology data to the caNanoLab data repository ( The objective is to curate cancer nanotechnology data under defined conditions in order to expedite the use of these data in the development of novel agents for cancer diagnostics and therapeutics. In order to do this, this survey is being conducted to learn what data sources are most relevant to you and to identify gaps in the caNanoLab database. We welcome your input and look forward to hearing from you.
OMB No. 0925-0642
Expiration Date: 9/30/2014
Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0642). Do not return the completed form to this address.

1. How did you learn about caNanoLab?

2. What caNanoLab features are you using? [choose one or more]

3. What caNanoLab content do you find the most useful for your purposes? [choose one or more]

4. What informatics tools are you currently using to manage and/or analyze your nanomaterial data?

5. What types of nanomaterials are you interested in? [choose one or more]

6. Do you feel that the database is deficient in any nanomaterials?

7. What kinds of characterization assays (e.g. cytotoxicity) are you interested in?

8. I am primarily employed in? [choose one]

9. I consider my field to be? [choose one or more]

10. Do you have any additional comments for feedback?